RetinalGenix Technologies Inc. Files 2024 Annual Report

Ticker: RTGN · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1836295

Retinalgenix Technologies Inc. 10-K Filing Summary
FieldDetail
CompanyRetinalgenix Technologies Inc. (RTGN)
Form Type10-K
Filed DateMar 31, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-K, annual-report, medical-devices

TL;DR

RetinalGenix filed its 2024 10-K. All systems go for medical tech.

AI Summary

RetinalGenix Technologies Inc. filed its 10-K for the fiscal year ending December 31, 2024, reporting its financial position and business operations. The company, incorporated in Delaware and headquartered in Petaluma, CA, operates in the surgical and medical instruments sector. Key financial data and operational details for the period are disclosed in this comprehensive annual report.

Why It Matters

This filing provides investors and stakeholders with a detailed overview of RetinalGenix Technologies Inc.'s financial health and strategic direction for the past fiscal year, crucial for investment decisions.

Risk Assessment

Risk Level: medium — As a publicly traded company filing a 10-K, there are inherent risks associated with financial reporting and market performance.

Key Numbers

  • 2024-12-31 — Fiscal Year End (The period covered by the 10-K filing.)
  • 2025-03-31 — Filing Date (The date the 10-K was officially submitted to the SEC.)
  • 333-258528 — SEC File Number (Unique identifier for the company's SEC filings.)

Key Players & Entities

  • RetinalGenix Technologies Inc. (company) — Filer of the 10-K
  • Petaluma, CA (location) — Business and mailing address
  • 3841 (industry_code) — Standard Industrial Classification for Surgical & Medical Instruments & Apparatus
  • 2024-12-31 (date) — Fiscal year end for the report
  • 2025-03-31 (date) — Filing date of the report

FAQ

What is the primary business of RetinalGenix Technologies Inc.?

RetinalGenix Technologies Inc. operates in the Surgical & Medical Instruments & Apparatus sector, SIC code 3841.

When did RetinalGenix Technologies Inc. file its 10-K report?

The 10-K report was filed on March 31, 2025.

What fiscal year does this 10-K filing cover?

This 10-K filing covers the fiscal year ending December 31, 2024.

Where is RetinalGenix Technologies Inc. located?

The company's business and mailing address is 1450 North McDowell Boulevard, Suite 150, Petaluma, CA 94954.

What is the company's state of incorporation?

RetinalGenix Technologies Inc. is incorporated in Delaware (DE).

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding RetinalGenix Technologies Inc. (RTGN).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.